Literature DB >> 21992958

Recommendations for probiotic use-2011 update.

Martin H Floch1, W Allan Walker, Karen Madsen, Mary Ellen Sanders, George T Macfarlane, Harry J Flint, Levinus A Dieleman, Yehuda Ringel, Stefano Guandalini, Ciaran P Kelly, Lawrence J Brandt.   

Abstract

This study describes the consensus opinion of the participants of the third Yale Workshop on probiotic use. There were 10 experts participating. The recommendations update those of the first 2 meetings that were published in 2005 and 2008. The workshop presentations and papers in this supplement relate to the involvement of normal microbiota involved in intestinal microecology, how the microbes interact with the intestine to affect our immunologic responses, the stability and natural history of probiotic organisms, and the role of the intestinal microbatome with regard to affecting cardiac risk factors and obesity. Recommendations for the use of probiotics in necrotizing enterocolitis, childhood diarrhea, inflammatory bowel disease, irritable bowel syndrome, and Clostridium difficile diarrhea are reviewed. As in previous publications, the recommendations are given as A, B, or C ratings. The recent positive experiences with bacteriotherapy (fecal microbiome transplant) are also discussed in detail and a positive recommendation is made for use in severe resistant C. difficile diarrhea.

Entities:  

Mesh:

Year:  2011        PMID: 21992958     DOI: 10.1097/MCG.0b013e318230928b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  65 in total

Review 1.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

Review 2.  Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.

Authors:  Ava Behrouzi; Hoora Mazaheri; Sarvenaz Falsafi; Zahra Hoseini Tavassol; Arfa Moshiri; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-05-01

Review 3.  Nothing in medicine makes sense, except in the light of evolution.

Authors:  Ajit Varki
Journal:  J Mol Med (Berl)       Date:  2012-04-27       Impact factor: 4.599

Review 4.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

5.  [Microbiome and nutrition. The way to a future therapy for chronic inflammatory bowel diseases?].

Authors:  S Schreiber; S Nikolaus; P Rosenstiel
Journal:  Internist (Berl)       Date:  2014-08       Impact factor: 0.743

Review 6.  Actual concept of "probiotics": is it more functional to science or business?

Authors:  Michele Caselli; Francesca Cassol; Girolamo Calò; John Holton; Giovanni Zuliani; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

7.  PURLs: prescribing an antibiotic? Pair it with probiotics.

Authors:  Blake Rodgers; Kate Kirley; Anne Mounsey
Journal:  J Fam Pract       Date:  2013-03       Impact factor: 0.493

Review 8.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 9.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 10.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.